Literature DB >> 17039085

Recurrent alveolar hemorrhage and pulmonary capillaritis in the "primary" antiphospholipid syndrome.

R A Asherson1, M A Greenblatt.   

Abstract

Pulmonary involvement in the primary antiphospholipid syndrome (PAPS) has generally been on the basis of thromboembolism. We describe a patient with hemorrhagic alveolitis, a life-threatening complication that must also be considered. The patient was a 63-year-old Caucasian man who had a past history of recurrent deep vein thromboses as well as an arterial occlusion of the left popliteal artery and who developed hemorrhagic alveolitis and capillaritis at age 57 years, which was treated with long-term cyclophosphamide, steroids, and anticoagulation. Four years later, he had a recurrence of the same condition, and a positive lupus anticoagulant test was found. Severe thrombocytopenia, diagnosed as idiopathic thrombocytopenic purpura, was treated with platelet transfusions and increasing steroid dosage. Hemorrhagic adrenal infarction supervened at this time, and a septicemic illness was treated with intravenous antibiotics. Diffuse alveolar pulmonary hemorrhage is an unusual complication of the APS that is being increasingly reported, and recognition of its possible fatal course is of great importance for the treating physician. Severe thrombocytopenia that could contribute to hemorrhage may also accompany the APS, but this is unusual.

Entities:  

Year:  2001        PMID: 17039085     DOI: 10.1097/00124743-200102000-00007

Source DB:  PubMed          Journal:  J Clin Rheumatol        ISSN: 1076-1608            Impact factor:   3.517


  7 in total

1.  A 37-Year-Old Man With Primary Antiphospholipid Syndrome Presenting With Respiratory Distress and Worsening Toe Ischemia.

Authors:  Nayef M Kazzaz; Allecia M Wilson; Ruba Kado; Geoffrey D Barnes; Jason S Knight
Journal:  Arthritis Care Res (Hoboken)       Date:  2017-08       Impact factor: 4.794

Review 2.  The lung in the antiphospholipid syndrome.

Authors:  G Espinosa; R Cervera; J Font; R A Asherson
Journal:  Ann Rheum Dis       Date:  2002-03       Impact factor: 19.103

Review 3.  Antiphospholipid syndrome and vascular ischemic (occlusive) diseases: an overview.

Authors:  Penka A Atanassova
Journal:  Yonsei Med J       Date:  2007-12-31       Impact factor: 2.759

4.  Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival.

Authors:  Nayef M Kazzaz; Patrick Coit; Emily E Lewis; W Joseph McCune; Amr H Sawalha; Jason S Knight
Journal:  Lupus Sci Med       Date:  2015-09-23

5.  Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort.

Authors:  Javier Narváez; Helena Borrell; Fernando Sánchez-Alonso; Iñigo Rúa-Figueroa; Francisco Javier López-Longo; María Galindo-Izquierdo; Jaime Calvo-Alén; Antonio Fernández-Nebro; Alejandro Olivé; José Luis Andreu; Víctor Martínez-Taboada; Joan Miquel Nolla; José María Pego-Reigosa
Journal:  Arthritis Res Ther       Date:  2018-12-19       Impact factor: 5.156

6.  Continous Rituximab treatment for recurrent diffuse alveolar hemorrhage in a patient with systemic lupus erythematosus and antiphosholipid syndrome.

Authors:  Signe Aakjær; Elisabeth Bendstrup; Per Ivarsen; Line Bille Madsen
Journal:  Respir Med Case Rep       Date:  2017-09-30

Review 7.  Clinical Insights into Diffuse Alveolar Hemorrhage in Antiphospholipid Syndrome.

Authors:  Sarah Abramson Stoots; Lindsay Lief; Doruk Erkan
Journal:  Curr Rheumatol Rep       Date:  2019-09-06       Impact factor: 4.592

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.